Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
Global Medical Scrubs Market to Reach $85.8 Billion by 2033
Clinical & Pharma Global Medical Scrubs Market to Reach $85.8 Billion by 2033

The global medical scrubs industry is currently undergoing a massive transformation as healthcare facilities worldwide prioritize both staff comfort and strict infection control protocols. With the market projected to reach a valuation of $85.8 billion by 2033, the trajectory reflects a steady

New $3 Million Gift Boosts Heart Care at Cleveland Clinic Florida
Management & Administration New $3 Million Gift Boosts Heart Care at Cleveland Clinic Florida

The landscape of cardiovascular medicine is undergoing a profound transformation as philanthropic investment continues to bridge the gap between standard clinical protocols and the next generation of life-saving medical breakthroughs. At Cleveland Clinic Florida, a significant $3 million

Aristotle Fund Dumps EHealth Amid Stock Collapse
Tech & Innovation Aristotle Fund Dumps EHealth Amid Stock Collapse

The precipitous downfall of a once-promising company often sends ripples through the investment community, signaling a dramatic shift in confidence and strategic outlook. Such is the case for EHealth, Inc. (EHTH), an online health insurance agency that has recently seen one of its institutional

Regulatory Setbacks Doom PTC's DMD Drug Translarna
Clinical & Pharma Regulatory Setbacks Doom PTC's DMD Drug Translarna

The decade-long journey for a promising Duchenne muscular dystrophy treatment has reached a devastating conclusion, as PTC Therapeutics has officially withdrawn its application for Translarna from the U.S. market, marking the end of a contentious and ultimately unsuccessful bid for regulatory

Struggling After Service? What VA Help Is Available?
Care Providers Struggling After Service? What VA Help Is Available?

The transition from the structured, high-stakes environment of military service to the ambiguities of civilian life often carries unseen burdens that extend far beyond the visible scars of conflict. For many veterans, the internal battles with hyper-vigilance, the persistent echo of trauma in

Is the UK Creating a Fairer Path for New MedTech?
Tech & Innovation Is the UK Creating a Fairer Path for New MedTech?

The United Kingdom's healthcare landscape has long presented a paradox for medical technology innovators, where groundbreaking devices and diagnostics capable of transforming patient outcomes often face a fragmented and unpredictable journey to widespread adoption within the National Health Service

Can US Biomedical Research Recover From a Year of Chaos?
Clinical & Pharma Can US Biomedical Research Recover From a Year of Chaos?

The American biomedical research landscape has emerged into 2026 bearing the deep and complex scars of a profoundly turbulent year, navigating a delicate balance between a renewed sense of financial security and a pervasive anxiety over the integrity of its foundational institutions. Following a

Closing the Diversity Gap in Parkinson's Research
Clinical & Pharma Closing the Diversity Gap in Parkinson's Research

The global map of Parkinson's disease is rapidly being redrawn, yet the landscape of the research dedicated to conquering it remains stubbornly fixed. A profound and widening disparity now exists between the populations most affected by this neurodegenerative condition and the focus of scientific

Healthcare's Digital Future Hinges on the Basics
Tech & Innovation Healthcare's Digital Future Hinges on the Basics

As an expert in robotics and IoT applications in medicine, James Maitland has dedicated his career to a powerful, singular passion: leveraging technology to advance healthcare solutions. Yet, he cautions that the industry's rush toward futuristic concepts like AI and virtual hospitals often

Can Vynca's New CMO Redefine Serious Illness Care?
Management & Administration Can Vynca's New CMO Redefine Serious Illness Care?

The landscape of serious illness care in the United States is fraught with challenges, leaving millions of vulnerable patients and their families navigating a fragmented and often reactive healthcare system. In this high-stakes environment, health technology company Vynca has made a definitive move

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later